NCT02465047

Brief Summary

Background: Epilepsy and nonepileptic attack disorder (NEAD) are chronic conditions that cause many patients to experience a great degree of stress in their everyday lives. Patients have also reported stress as the commonest trigger of their seizures, and animal studies suggest that stress can make seizures worse. A self-help intervention that would help people manage the stress they experience could therefore improve their quality of life and have positive effects on the frequency of their seizures. Research Question: The study evaluates whether a self-help intervention in the form of a brief booklet can improve the quality of life and reduce the levels of stress of people who experience seizures. In addition, the study will explore the associations between seizure severity and frequency, physiological and self-reported stress, and anxiety and depression. Design: The researchers are recruiting patients attending the Outpatient Neurology Clinic at the Royal Hallamshire Hospital and measure their quality of life and stress levels before, one month and two months after they have been given the self-help stress reduction booklet. The researchers will measure the changes in quality of life and stress levels using questionnaires and saliva samples.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 17, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 8, 2015

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
Last Updated

May 16, 2016

Status Verified

May 1, 2016

Enrollment Period

10 months

First QC Date

April 17, 2015

Last Update Submit

May 13, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Health-related Quality of Life

    2 months

Study Arms (2)

Self-help booklet

EXPERIMENTAL

The intervention consists of a brief A5 self-help stress management booklet with an audio Compact Disk.

Other: Self-help booklet

Delayed Intervention

NO INTERVENTION

Participants do not receive the intervention until one month after the initial assessment.

Interventions

See Arm/Group Description

Self-help booklet

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Clinically firm diagnosis of epilepsy (and no additional NEAD) or NEAD (and no additional epilepsy)
  • Over the age of 16 years
  • Able to complete the self-report questionnaires and diary measure without help
  • Able to give informed consent

You may not qualify if:

  • Patients likely to have mixed seizure disorders (epilepsy and NEAD)
  • People who are unable to give informed consent
  • People who are unable to complete the self-report questionnaires and diary measure unaided
  • People who have not experienced a seizure within the last 12 months
  • People whose diagnosis remains uncertain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sheffield Teaching Hospitals NHS Foundation Trust

Sheffield, S10 2 JF, United Kingdom

Location

MeSH Terms

Conditions

EpilepsyPsychogenic Nonepileptic Seizures

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesSeizuresNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Markus Reuber, Professor

    University of Sheffield

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2015

First Posted

June 8, 2015

Study Start

November 1, 2014

Primary Completion

September 1, 2015

Study Completion

September 1, 2015

Last Updated

May 16, 2016

Record last verified: 2016-05

Locations